Interobserver reproducibility of immunocytochemical estrogen- and progesterone receptor status assessment in breast cancer

Anticancer Research

Volumn 16, Issue 5 A, 1996, Pages 2497-2500

  Biesterfeld, Stefan ^a   Veuskens, Ursula ^a   Schmitz, Franz Josef ^a   Amo Takyi, Baffour ^a   Böcking, Alfred ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Breast cancer; Estrogen and progesterone receptors; Immunocytochemistry

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ARTICLE; BREAST CARCINOMA; CLINICAL TRIAL; FEMALE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOCYTOCHEMISTRY; MAJOR CLINICAL STUDY; OBSERVER VARIATION; PRIORITY JOURNAL; REPRODUCIBILITY;

BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; OBSERVER VARIATION; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; REPRODUCIBILITY OF RESULTS;

EID: 0029858876     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Allred DC, Bustamante A, Daniel OC, Gaskill HV, Cruz AB: Immunocytochemical analysis of estrogen receptors in human breast cancer. Arch Surg 125: 107-113, 1990.
2. Remmele W, Stegner HE: Vorschlag zur einheitlichen Definition eines Immunreaktiven Score (IRS) für den immunhistochemischen Östrogenrezeptor-Nachweis (ER-ICA) im Mammakarzinomgewebe. Pathologe 8: 138-140, 1986.
3. Reiner A, Reiner G, Spona J, Teleky B, Kolb R, Holzner JH: Estrogen receptor immunocytochemistry for preoperative determination of estrogen receptor status on fine-needle aspirates of breast cancer. Am J Clin Pathol 88: 399-404, 1987.
4. Jonat W, Maass H, Stegner HE: Immunohistochemical measurement of estrogen receptors in breast cancer tissue samples. Cancer Res (Suppl) 46: 4296s-4298s, 1986.
5. Marchetti E, Querzoli P, Moncharmont B, Parikh I, Bagni A, Marzola A, Fabris G, Nenci I: Immunocytochemical demonstration of estrogen receptors by monoclonal antibodies in human breast cancer: Correlation with estrogen receptor assay by dextran-coated charcoal method. Cancer Res 47: 2508-2513, 1987.
6. Kinsel LB, Szabo E, Greene GL, Konrath J, Leight GS, McCarty KS: Immunocytochemical analysis of.estrogen receptors as a predictor of prognosis in breast cancer patients: Comparison with quantitative biochemical methods. Cancer Res 49: 1052-1056, 1989.
7. McClelland RA, Wilson D, Leake R, Finlay P, Nicholson RI (on behalf of the British Quality Control Group): A multicentre study into the reliability of steroid receptor immunocytochemical assay quantification. Eur J Cancer 27: 711-715, 1991.
8. Bloom HJG, Richardson WH: Histological grading and prognosis in breast cancer. Br J Cancer 11: 359-377, 1957
9. Champion HR, Wallace IWJ: Breast cancer grading. Cancer 25: 441-448, 1971.
10. Stenkvist B, Westman-Naeser S, Vegelius J, Holmquist J, Nordin J, Bengtson F, Eriksson O: Analysis of reproducibility of subjective grading systems for breast carcinoma. J Clin Pathol 32: 979-983, 1979.
11. Stenkvist B, Bengtsson E, Eriksson O, Jarkrans T, Nordin B, Westman-Naeser S: Histopathological systems of breast cancer classification: reproducibility and clinical significance. J Clin Pathol 36: 392-398, 1983.
12. Sundblad AS, Paz RA, Ghioldi NS, Bertranou EG: Reproducibilidad del grado histologico en el carcinoma de mama. Medicina 46: 649-652, 1986.
13. Theissig F, Kunze KD, Haroske G, Meyer W: Histological grading of breast cancer. Interobserver reproducibility and prognostic significance. Path Res Pract 186: 732-736, 1990.
14. Frierson HF, Wolber RA, Berean KW, Franquemont DW, Gaffey MJ, Boyd JC, Wilbur DC: Interobserver reproducibility of teh Nottingham modification of the Bloom and Richardson histologic grading scheme for infiltrating ductal carcinoma. Am J Clin Pathol 103: 195-199, 1995.
15. Dalton LW, Page DL, Dupont WD: Histologic grading of breast carcinoma. A reproducibility study. Cancer 73: 2765-2770, 1994.
16. Robbins P, Pinder S, de Klerk N, Dwakins H, Harvey J, Sterrett G, Ellis I, Elston C: Histological grading of breast carcinomas: a study of interobserver agreement. Hum Pathol 26: 873-879, 1995.
17. Biesterfeld S, Pollmann I, Böcking A: Grading of malignancy in urothelial carcinoma. Path Res Pract 185: 18-19, 1989.
18. Svanholm H, Mygind H: Prostatic carcinoma. Reproducibility of histologic grading. Acta Pathol Microbiol Immunol Scand A 93: 67-71, 1985.
19. Anneroth G, Hansen LS: A methodologic study of histologic classification and grading of malignancy in oral squamous cell carcinoma. Scand J Dent Res 92: 448-468, 1984.
20. Iino Y, Sugamata N, Maemura M, Takeo T, Owada S, Yokoe T, Ishikata T, Horiuci R, Morishita Y: Intersite variation of estrogen receptors in human breast cancers and response to endocrine therapy. Oncology 49: 89-92, 1992.
21. Bacus S, Flowers JL, Press MF, Bacus JW, McCarthy KS: The evaluation of estrogen receptor in primary breast carcinoma by computer-assisted image analysis. Am J Clin Pathol 90: 233-239, 1988.
22. Müller W, Böcking A, Auer H: TV cytometer CM1 for computer aided tumor diagnosis. In: Wied GL, Bartels PH, Rosenthal DL, Schenck U (Eds.): Compendium on the computerized cytology and histology laboratory. Tutorials of Cytology, Chicago, USA, pp. 376-388, 1994.